American Conference Institute (ACI) will be holding its 19th Advanced Summit on Life Sciences Patents conference on July 21-22, 2021 as a virtual conference.
The conference will offer presentations on the following topics:
• Refining global patenting strategies in the U.S., Europe, China, and Brazil
• Gauging the continued impact of the COVID-19 pandemic, including compulsory licensing and march-in rights
• A PTAB year in review, including latest developments at the Board, the Federal Circuit, and an update on the Arthrex case
• Future landscape of Section 101: Will there ever be clarity?
• An international perspective on written description and enablement standards in antibody claims
• Examining the recent surge in doctrine of equivalents decisions
• Developments in patent term extensions in the U.S. and Europe, including the implications of Biogen v. Banner and Europe's SVC manufacturing waiver
• Obviousness, obviousness-type double patenting, and inherency
• Method of treatment and second medical use claims, personalized medicine and dosage regime patents
• Separate interactive sessions from life sciences litigators regarding what they wish the prosecutor had done, the implications on skinny labels of GSK v. Teva, and ethical dilemmas in patent prosecution
The registration fee for the conference is $1,595 if registered and paid by July 2nd and $1,695 if registered and paid by July 20th. There is an in-house counsel rate of $1,295 available until July 20th. Patent Docs readers are entitled to a 10% discount off of registration using discount code D10-762-762DX03. Those interested in registering for the conference can do so here, by e-mailing CustomerService@AmericanConference.com, or by calling 1-888-224-2480.
Patent Docs is a media partner of ACI's 19th Advanced Summit on Life Sciences Patents Conference.
Comments